No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: Evidence from a literature-based meta-analysis

Breast Cancer Research and Treatment

Volumn 122, Issue 3, 2010, Pages 853-858

  Yu, Ke Da ^a   Chen, Ao Xiang ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; Progesterone receptor; rs10895068; Susceptibility

Indexed keywords

PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; BREAST NEOPLASMS; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PROGNOSIS;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 77955551986     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0738-x     Document Type: Article

References (31)

1. JD Yager NE Davidson 2006 Estrogen carcinogenesis in breast cancer N Engl J Med 354 270 282 10.1056/NEJMra050776 1:CAS:528:DC%2BD28Xls1KjtQ%3D%3D 16421368 (Pubitemid 43113032)
2. SE Hankinson WC Willett JE Manson GA Colditz DJ Hunter D Spiegelman RL Barbieri FE Speizer 1998 Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women J Natl Cancer Inst 90 1292 1299 10.1093/jnci/90.17.1292 1:CAS:528:DyaK1cXmtVaisrg%3D 9731736
3. AMGZ Ladd AA Vasquez F Rivadeneira C Siemes A Hofman BH Stricker HA Pols AG Uitterlinden CM van Duijn 2008 Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk Breast Cancer Res Treat 107 415 419 10.1007/s10549-007-9562-3 (Pubitemid 351172114)
4. B Diergaarde JD Potter ER Jupe S Manjeshwar CD Shimasaki TW Pugh DC Defreese BA Gramling I Evans E White 2008 Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer Cancer Epidemiol Biomarkers Prev 17 1751 1759 10.1158/1055-9965.EPI-08-0168 1:CAS:528:DC%2BD1cXosFGhtr4%3D 18628428
5. V Beral E Banks G Reeves 2002 Evidence from randomised trials on the long-term effects of hormone replacement therapy Lancet 360 942 944 10.1016/S0140-6736(02)11032-4 12354487 (Pubitemid 35283842)
6. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321 333 10.1001/jama.288.3.321 1:CAS:528:DC%2BD38Xltlegs7k%3D 12117397
7. C Campagnoli F Clavel-Chapelon R Kaaks C Peris F Berrino 2005 Progestins and progesterone in hormone replacement therapy and the risk of breast cancer J Steroid Biochem Mol Biol 96 95 108 10.1016/j.jsbmb.2005.02.014 1:CAS:528:DC%2BD2MXntVOht74%3D 15908197 (Pubitemid 41096673)
8. W Zheng J Long YT Gao C Li Y Zheng YB Xiang W Wen S Levy SL Deming JL Haines K Gu AM Fair Q Cai W Lu XO Shu 2009 Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1 Nat Genet 41 324 328 10.1038/ng.318 1:CAS:528:DC%2BD1MXhvFKjtbo%3D 19219042
9. J Wang R Higuchi F Modugno J Li N Umblas J Lee LY Lui E Ziv JA Tice SR Cummings B Rhees 2007 Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women Breast Cancer Res Treat 106 273 280 10.1007/s10549-007-9497-8 1:CAS:528:DC%2BD2sXht1Cgt7fP 17268813 (Pubitemid 350045020)
10. P Maguire S Margolin J Skoglund XF Sun JA Gustafsson AL Borresen-Dale A Lindblom 2005 Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer Breast Cancer Res Treat 94 145 152 10.1007/s10549-005- 7697-7 1:CAS:528:DC%2BD2MXhtFKktrrK 16261413 (Pubitemid 41547111)
11. M Aupperlee A Kariagina J Osuch SZ Haslam 2005 Progestins and breast cancer Breast Dis 24 37 57 1:CAS:528:DC%2BD28XotFKhu7o%3D 16917138
12. JP Lydon G Ge FS Kittrell D Medina BW O'Malley 1999 Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function Cancer Res 59 4276 4284 1:CAS:528:DyaK1MXlvVSms78%3D 10485472
13. SM Rowe SJ Coughlan NJ McKenna E Garrett DG Kieback DN Carney DR Headon 1995 Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion Cancer Res 55 2743 2745 1:CAS:528:DyaK2MXmsFyksro%3D 7796397
14. IU Agoulnik XW Tong DC Fischer K Korner NE Atkinson DP Edwards DR Headon NL Weigel DG Kieback 2004 A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk J Clin Endocrinol Metab 89 6340 6347 10.1210/jc.2004-0114 1:CAS:528:DC%2BD2cXhtFSit7rK 15579801 (Pubitemid 39628457)
15. I De Vivo GS Huggins SE Hankinson PJ Lescault M Boezen GA Colditz DJ Hunter 2002 A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk Proc Natl Acad Sci USA 99 12263 12268 10.1073/pnas.192172299 12218173
16. S Wang-Gohrke J Chang-Claude H Becher DG Kieback IB Runnebaum 2000 Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50 Cancer Res 60 2348 2350 1:CAS:528:DC%2BD3cXjtV2qsbc%3D 10811106
17. KA Pooley CS Healey PL Smith PD Pharoah D Thompson L Tee J West C Jordan DF Easton BA Ponder AM Dunning 2006 Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach Cancer Epidemiol Biomarkers Prev 15 675 682 10.1158/1055-9965.EPI-05-0679 1:CAS:528:DC%2BD28XjsVWrt7g%3D 16614108
18. MM Gaudet RL Milne A Cox NJ Camp EL Goode MK Humphreys AM Dunning J Morrison GG Giles G Severi L Baglietto DR English FJ Couch JE Olson X Wang J Chang-Claude D Flesch-Janys S Abbas R Salazar A Mannermaa V Kataja VM Kosma A Lindblom S Margolin T Heikkinen K Kampjarvi K Aaltonen H Nevanlinna N Bogdanova I Coinac P Schurmann T Dork CR Bartram RK Schmutzler S Tchatchou B Burwinkel H Brauch D Torres U Hamann C Justenhoven G Ribas JI Arias J Benitez SE Bojesen BG Nordestgaard HL Flyger J Peto O Fletcher N Johnson I Dos Santos Silva PA Fasching MW Beckmann R Strick AB Ekici A Broeks MK Schmidt FE van Leeuwen LJ Van't Veer MC Southey JL Hopper C Apicella CA Haiman BE Henderson L Le Marchand LN Kolonel V Kristensen G Grenaker Alnaes DJ Hunter P Kraft DG Cox SE Hankinson C Seynaeve MP Vreeswijk RA Tollenaar P Devilee S Chanock J Lissowska L Brinton B Peplonska K Czene P Hall Y Li J Liu S Balasubramanian S Rafii MW Reed KA Pooley D Conroy C Baynes D Kang KY Yoo DY Noh SH Ahn CY Shen HC Wang JC Yu PE Wu H Anton-Culver A Ziogoas K Egan P Newcomb L Titus-Ernstoff A Trentham Dietz AJ Sigurdson BH Alexander P Bhatti K Allen-Brady LA Cannon-Albright J Wong G Chenevix-Trench AB Spurdle J Beesley PD Pharoah DF Easton M Garcia-Closas 2009 Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium Cancer Epidemiol Biomarkers Prev 18 1610 1616 10.1158/1055-9965.EPI-08-0745 1:CAS:528:DC%2BD1MXlsFCltLc%3D 19423537
19. I De Vivo SE Hankinson GA Colditz DJ Hunter 2003 A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk Cancer Res 63 5236 5238 14500352
20. LP Fernandez RL Milne E Barroso M Cuadros JI Arias A Ruibal J Benitez G Ribas 2006 Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study Int J Cancer 119 467 471 10.1002/ijc.21847 1:CAS:528:DC%2BD28XmsVOjtbc%3D 16477637
21. HS Feigelson C Rodriguez EJ Jacobs WR Diver MJ Thun EE Calle 2004 No association between the progesterone receptor gene +331G/A polymorphism and breast cancer Cancer Epidemiol Biomarkers Prev 13 1084 1085 10.1158/1055-9965. EPI-03-0301 1:CAS:528:DC%2BD2cXks1Shtb4%3D 15184270 (Pubitemid 38222552)
22. KD Yu AX Chen C Yang LX Qiu L Fan WH Xu ZM Shao 2009 Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis Breast Cancer Res Treat 10.1007/s10549-009-0688-3
23. KD Yu GH Di L Fan J Wu Z Hu ZZ Shen W Huang ZM Shao 2009 A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer FASEB J 23 2274 2287 10.1096/fj.08-124073 1:CAS:528: DC%2BD1MXosVCns78%3D 19228880
24. LX Qiu B Chen C Mao P Zhan H Yuan K Xue J Li XC Hu 2009 STK15 F31I polymorphism is associated with breast cancer risk: a meta-analysis involving 25, 014 subjects Breast Cancer Res Treat 118 599 603 10.1007/s10549-009-0574-z 1:CAS:528:DC%2BD1MXhtlyls7%2FI
25. CL Pearce JN Hirschhorn AH Wu NP Burtt DO Stram S Young LN Kolonel BE Henderson D Altshuler MC Pike 2005 Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis J Natl Cancer Inst 97 51 59 10.1093/jnci/dji007 1:CAS:528:DC%2BD2MXisVaqtQ%3D%3D 15632380
26. GS Huggins JY Wong SE Hankinson I De Vivo 2006 GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism Cancer Res 66 1384 1390 10.1158/0008-5472.CAN-05-2715 1:CAS:528:DC%2BD28XpsVehsw%3D%3D 16452193 (Pubitemid 43259918)
27. A Romano PJ Lindsey DC Fischer B Delvoux AD Paulussen RG Janssen DG Kieback 2006 Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer Gynecol Oncol 101 287 295 10.1016/j.ygyno.2005.10.040 1:CAS:528:DC%2BD28XksFyjsrc%3D 16360811
28. SE Johnatty AB Spurdle J Beesley X Chen JL Hopper DL Duffy G Chenevix-Trench 2008 Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies Breast Cancer Res Treat 109 91 99 10.1007/s10549-007-9627-3 1:CAS:528:DC%2BD1cXkslKhsrw%3D 17592773 (Pubitemid 351538757)
29. KW Reding CI Li NS Weiss C Chen CS Carlson D Duggan KE Thummel JR Daling KE Malone 2009 Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk Am J Epidemiol 170 1241 1249 10.1093/aje/kwp298 19846565
30. J Kotsopoulos SS Tworoger I De Vivo SE Hankinson DJ Hunter WC Willett WY Chen 2009 +331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer Int J Cancer 125 1685 1691 10.1002/ijc.24477 1:CAS:528:DC%2BD1MXpsVKmsLk%3D 19462450
31. DA Ralph LP Zhao CE Aston S Manjeshwar TW Pugh DC DeFreese BA Gramling CD Shimasaki ER Jupe 2007 Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk Cancer 109 1940 1948 10.1002/cncr.22634 1:CAS:528:DC%2BD2sXmtV2qs78%3D 17436274 (Pubitemid 46744186)